The next two discretionary priority vouchers to be awarded by the FDA are reported to be heading for two MSD candidates with blockbuster potential. According to Reuters, MSD – known as Merck & Co in ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

Head of the Hei in Jujutsu Shenanigans is a playable fighter inspired by Noya Zenin from Jujutsu Kaisen. This character is one of the more mechanically complex fighters in the experience, requiring ...

Nearly 50 years ago, in the late 1970s, Autotronic Control Corporation began experimenting with multiple spark discharge (MSD) ignition technology as an alternative to the inductive ignitions used in ...

Select an option below to continue reading this premium story. Already a Honolulu Star-Advertiser subscriber? Log in now to continue reading. The same filing states that seven other lawsuits filed ...

Aerospace and defense company HEICO (NSYE:HEI) will be announcing earnings results this Thursday afternoon. Here’s what to look for. HEICO beat analysts’ revenue expectations by 3% last quarter, ...

CNBC's Robert Frank sits down for a rare and exclusive interview with bankers to America's wealthiest families, Byron Trott and Gregg Lemkau, co-CEOs of BDT & MSD Partners. Got a confidential news tip ...

Enlicitide significantly reduces LDL-C in patients with high cardiovascular risk MSD has announced positive results from its phase 3 CORALreef Lipids trial, showing that enlicitide decanoate, an ...

Point and Blue Owl Capital have completed a $390 million securitization of home equity investment assets, marking the largest bond issuance in the history of the HEI space. This transaction reflects ...

RIYADH, Saudi Arabia: Lifera, a PIF Company, announces the signing of a non-binding Memorandum of Understanding (MOU) with MSD (also known as Merck & Co., Inc., Rahway, N.J., USA in the U.S. and ...

Merck & Co (MSD) has broken ground on its new pharmaceutical manufacturing Centre of Excellence in Virginia, US, amid looming tariff threats from the Trump administration. The $3bn site, which is ...